The first case had a CNV involving three genes (FBN2, MEGF10, and PITX1), while the second case had a CNV involving ZC4H2. As we continue to learn more about genetic mechanisms responsible for AMC we anticipate the ability to better provide prognostic information and targeted therapies for affected patients. This evidence concerns the gene ZC4H2 and arthrogryposis multiplex congenita.